Description
SARS-CoV-1 spike S glycoprotein pseudotyped viral particles (SARS-CoV-1 pseudovirions) carry tGFP, so it allows to monitor virus infection. SARS-CoV-1 pseudovirions can be used to perform drug screening or quantify neutralizing antibodies.
We offer both SARS-COV-1 spike S glycoprotein pseudotyped viral particles (SARS-CoV-1 pseudovirions) and SARS-COV-2 spike S glycoprotein pseudotyped viral particles (SARS-CoV-2 pseudovirions). Both pseudotyped viral particles carry tGFP and allow to monitor virus infection.
